内质网
细胞生物学
生物
脂肪生成
激酶
脂质代谢
脂滴
LNCaP公司
甾醇调节元件结合蛋白
蛋白激酶A
前列腺癌
未折叠蛋白反应
脂肪酸合酶
内体
葛兰素史克-3
极光A激酶
癌症研究
平衡
癌细胞
细胞
生物化学
脂肪酸合成
作者
Yang Zheng,Caleb Cheng,Yizhi Cao,Gabriel Cruz,Yuping Zhang,Radha Paturu,Somnath Mahapatra,Jing Hu,Rahul Mannan,Hüseyin Karabürk,Rupam Bhattacharyya,Yitong Yin,Yi Zhao,Wenyan Liu,Xuhong Cao,Hui Xue,Chungen Li,Zhen Wang,Stephanie J. Miner,Zachery Roger Reichert
出处
期刊:Cancer Cell
[Cell Press]
日期:2026-08-03
卷期号:44 (9): 1761-1778.e12
标识
DOI:10.1016/j.ccell.2026.07.003
摘要
Neuroendocrine prostate cancer (NEPC) persists in a profoundly hypoxic microenvironment, yet the mechanisms enabling tumor adaptation to this metabolically challenging niche remain undefined. Here, we identify the lipid kinase PIKfyve as overexpressed in NEPC, functioning as a central node in a stress-adaptive lipid kinase axis that supports adaptation to persistent endoplasmic reticulum (ER) stress. Mechanistically, NEPC requires PIKfyve-mediated lysosomal degradation and lipid recycling to maintain metabolic homeostasis under hypoxia. PIKfyve inhibition disrupts lysosomal function, exacerbates ER stress, and activates a compensatory sterol regulatory element-binding protein (SREBP)-dependent de novo lipogenesis program essential for NEPC survival. This stress-lipid axis creates a synthetic vulnerability between PIKfyve and fatty acid synthase (FASN), where dual inhibition synergistically amplifies ER stress, triggers the terminal unfolded protein response, and induces tumor cell death. These findings reveal a metabolic adaptation in NEPC and provide preclinical evidence that co-targeting PIKfyve and FASN can overcome hypoxia-associated stress adaptation.
科研通智能强力驱动
Strongly Powered by AbleSci AI